We are live on
!
Find out more
GS
Gilead Sciences Portfolio holdings
AUM
$2.12B
1-Year Est. Return
143.53%
This Fund
S&P 500
1 Year Est. Return
+143.53%
AUM
$2.12B
AUM Growth
+$182M
(+9.4%)
Holding
6
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACLX
1
DELISTED
Arcellx
ACLX
| $772M | 36.44% |
6,720,803
|
|
||
2
Arcus Biosciences
RCUS
$2.96B
| $679M | 32.05% |
31,424,760
|
|
||
|
LKFT
3
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.85B
| $501M | 23.67% |
16,707,477
|
|
||
4
Assembly Biosciences
ASMB
$458M
| $125M | 5.9% |
4,505,391
|
|
||
5
Kyverna Therapeutics
KYTX
$480M
| $35.6M | 1.68% |
4,126,119
|
|
||
6
Xilio Therapeutics
XLO
$54M
| $5.47M | 0.26% |
650,389
|
|